Connect with us

News

Lassa Fever Fatality Rate Rises In Nigeria As Cases Fall

info

Published

on

Lassa fever

By Abujah Racheal

The Nigeria Centre for Disease Control and Prevention (NCDC) says Nigeria is recording a rising Lassa fever fatality rate.

This is in spite of a decline in weekly confirmed cases, raising fresh concerns over disease management nationwide.

The agency disclosed on Wednesday in its Epidemiological Week 14 report for 2026 that confirmed cases dropped from 26 in the previous week to 22, while the case fatality rate rose significantly.

It said the Case Fatality Rate increased to 24.8 per cent, compared to 18.8 per cent recorded during the same period in 2025, indicating worsening outcomes in spite of fewer infections.

It said cumulatively, Nigeria had recorded 170 deaths from Lassa fever in 2026, underscoring persistent challenges related to early detection, timely treatment, and health-seeking behaviour across affected communities nationwide.

The report showed that 22 states and 94 Local Government Areas had reported confirmed cases in 2026, with five states accounting for about 84 per cent of total infections recorded.

It said the states included Bauchi, Ondo, Taraba, Edo, and Benue, which continued to bear the highest burden of the disease, reflecting regional concentration of infections and transmission patterns.

The agency said Bauchi recorded the highest burden with 27 per cent of confirmed cases, followed by Ondo with 22 per cent, Taraba with 18 per cent, Edo with nine per cent, and Benue.

Other affected states included Plateau, Ebonyi, and Kogi, among others, highlighting the continued geographic spread of Lassa fever across multiple regions in spite of ongoing surveillance and response efforts nationwide.

The NCDC said that the predominant age group affected was between 21 and 30 years, with cases ranging from one to 90 years and a median age of 30 years.

It added that the male-to-female ratio among confirmed cases stood at 1:0.9, indicating relatively similar infection rates between genders, although slightly higher among males in the current reporting period.

The report also confirmed infections among healthcare workers during the reporting week, raising concerns about infection prevention and control compliance in treatment centres and frontline health facilities managing cases.

According to the agency, while suspected cases have declined, confirmed cases remain higher compared to the same period in 2025, suggesting sustained community transmission and gaps in containment measures.

The NCDC, in collaboration with partners including World Health Organization, UNICEF, Médecins Sans Frontières, and the US CDC, had activated a national response framework.

It said a multi-sectoral Incident Management System had been deployed to coordinate response efforts, improve surveillance, and strengthen interventions aimed at reducing transmission and fatalities across affected states.

The agency said interventions included infection prevention training for health workers, distribution of personal protective equipment, active case search, contact tracing, and community sensitisation campaigns in high-burden areas nationwide.

The agency added that rapid response teams had been deployed to seven high-burden states, while treatment centres continued receiving essential medical supplies including Ribavirin and protective equipment for case management.

In spite of these efforts, the NCDC highlighted ongoing challenges such as late presentation of cases, poor health-seeking behaviour due to high treatment costs, inadequate sanitation, and low public awareness in affected communities.

It urged state governments to strengthen community engagement, while advising healthcare workers to maintain a high index of suspicion for Lassa fever and strictly adhere to infection prevention protocols.

The agency emphasised that sustained multi-sectoral collaboration remained critical to reducing transmission, improving treatment outcomes, and lowering the number of deaths associated with Lassa fever across the country.

The News Agency of Nigeria (NAN) reports that Lassa fever is an acute viral haemorrhagic illness transmitted through contact with food or household items contaminated by infected rodents. (NAN) (www.nannews.ng)

Edited by Abiemwense Moru

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

The Extra Mile: PenCom marks 2026 Customer Service Week

info

Published

on

BY NKECHI NAECHE-ESEZOBOR—The National Pension Commission (PenCom) has joined in the celebration of Customer Service Week, aimed at celebrating retirees and workers in the country.

According to PenCom, day one of the week kicked off on a high note as staff celebrated their colleagues, customers and the commitment to going “the extra mile” in delivering exceptional customer experience.

From engaging conversations and interactive sessions to team spirit, smiles and celebrations, the opening day set the tone for a week focused on putting the customer at the heart of the Commission’s work.

This year, the Commission is reminded that great customer service is not just about meeting expectations; it is about exceeding them, creating value and making every interaction count.

The highlight of the event was the cutting of the cake by the Director-General of PenCom, Ms. Omolola Bridget Oloworaran, and her management team.

The post The Extra Mile: PenCom marks 2026 Customer Service Week appeared first on Business Today NG.

Continue Reading

News

Lucid Motors’ EV output falls to lowest level in almost 2 years

info

Published

on

Lucid gravity main.jpg

Lucid Motors built 2,954 electric vehicles (EVs) in the third quarter of this year, a 54% drop from a year ago, as the company purposely limits production to better meet demand for its EVs.

This was the third straight quarter in which the number of EVs Lucid built has declined. It’s also the lowest quarterly output since the first quarter of 2025, which was just after Lucid Motors started production of its second EV, the Gravity SUV.

Lucid delivered 3,806 EVs in the third quarter, roughly flat with the second quarter and down about 200 vehicles from the third quarter of 2025. The company has struggled to find buyers for either of its first two luxury EVs. In five of the last six quarters, it built more vehicles than it delivered.

Lucid’s new CEO, Silvio Napoli, has spent the last few months leading an effort to “simplify the company.” That effort has included laying off around 1,500 employees, streamlining the company’s leadership, and eliminating a second shift at its factory in Arizona in a bid to reach cost savings of $1.4 billion. Lucid also delayed the release of its third EV, the Cosmos. That model is supposed to be much cheaper, starting at under $50,000.

The third-quarter figures, released Monday afternoon, come just a few days after rival EV upstart Rivian posted its best quarter in history on the back of the R2, its new, more affordable SUV. Although Rivian didn’t break out specific delivery figures for the R2, the company shipped nearly 20,000 vehicles in the third quarter, the first full quarter with the R2 in production, up from 12,194 in the second quarter.

Lucid’s failure to find a large market of buyers for its EVs is even more stark when compared with the promises the company made when it went public in 2021. That year, Lucid Motors merged with a special purpose acquisition company and estimated it would ship as many as 90,000 EVs in 2024 alone. The company raised $4 billion in the transaction.

On Lucid’s second-quarter earnings call in August, Napoli spoke about why he thinks the company has failed to make a dent in the EV market.

“While there is no question that Lucid brought leading innovations and outstanding products to the market, we have disappointed on several fronts, and for far too long,” he said. “We have not executed consistently. We missed commitments, launched products before they were ready, underinvested in service, responded too slowly to quality issues, and allowed complexity to slow decisions down.”

The Cosmos’ lower price could, in theory, let Lucid access a wider market, but Napoli cautioned shareholders that rushing the new EV out could create more trouble.

“We will not repeat the mistakes of the past by bringing a product to market before it is ready,” Napoli said on the call.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Continue Reading

Trending